Viatris
Manufacturing · Pennsylvania, United States · 10K+ Employees
View Company Info for Free
Overview
Headquarters
1000 Mylan Blvd, Canonsburg, Pennsylvani...Phone Number
(724) 514-1800Website
www.viatris.comRevenue
$14.7 BillionStock Symbol
VTRSIndustry
About Viatris
Viatris Org Chart
Global General Counsel
Greater General Counsel (China)
Janz General Counsel
General Counsel (US)
合规总监
Is Viatris your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Viatris
Check if Viatris has recently received funding, and reach out quickly before it becomes old news!
Check out if Viatris is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Viatris recently announced quarterly report
Click to see if Viatris had a recent Job posting/layoffs
Viatris, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Viatris has new funding data
Product Launch: Get notified when Viatris launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Viatris is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Viatris is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Viatris.
Viatris Tech Stack
A closer look at the technologies used by Viatris
Most Recent Scoops
Viatris News & Media
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
The recent breakout of Moderna reminded investors that AI stocks aren’t the only destination to make money. Healthcare and biotech stocks offer promising long-term opportunities if chosen wisely. We ran an analysis based on Insider Monkey’s proprietary database of over 900 hedge funds to see which healthcare stocks trading under $20 billionaire-led funds were holding […]5 Must-Read Analyst Questions From Viatris’s Q2 Earnings Call
Viatris’ second-quarter results were met with a negative market reaction, despite the company surpassing Wall Street’s revenue and non-GAAP profit expectations. Management attributed the quarter’s performance to strong commercial execution in Greater China, where investments in established brands and e-commerce channels drove double-digit growth. CEO Scott Smith emphasized that demand for cardiovascular products and the company’s strategic focus on higher-margin generics in North America contribViatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine?
According to reports, on August 6, Harrow, Inc. (NASDAQ:HROW) announced a definitive agreement to acquire global rights to Tyrvaya nasal spray from Viatris Inc. (NASDAQ:VTRS) for up to $100 million. Under the deal terms, Harrow will pay $30 million in cash at closing, funded via cash on hand, with up to $70 million in contingent […]Viatris Inc. (VTRS) Q2 2026 Earnings Call Transcript
Viatris Inc. (VTRS) Q2 2026 Earnings Call August 6, 2026 8:30 AM EDTCompany ParticipantsWilliam Szablewski - Head of Investor Relations & Capital...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Viatris
Founded in 2020, Viatris empowers people worldwide to live healthier at every stage of life. They provide access to medicines, advance sustainable operations, develop innovative solutions, and leverage their collective expertise to improve patient health. Viatris is headquartered in Canonsburg, Pennsylvania.... Read More

